111 related articles for article (PubMed ID: 6722783)
1. In vivo effects of indomethacin on the growth of murine mammary tumors.
Fulton AM
Cancer Res; 1984 Jun; 44(6):2416-20. PubMed ID: 6722783
[TBL] [Abstract][Full Text] [Related]
2. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
3. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas.
Fulton AM; Heppner GH
Cancer Res; 1985 Oct; 45(10):4779-84. PubMed ID: 4027966
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages of mouse mammary tumors. II. Differential distribution of macrophages from metastatic and nonmetastatic tumors.
Mahoney KH; Fulton AM; Heppner GH
J Immunol; 1983 Oct; 131(4):2079-85. PubMed ID: 6311907
[TBL] [Abstract][Full Text] [Related]
6. What regulates placental steroidogenesis in 90-day pregnant ewes?
Weems YS; Kim L; Tsuda V; Yin C; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
[TBL] [Abstract][Full Text] [Related]
7. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
[TBL] [Abstract][Full Text] [Related]
9. Interactions of natural effector cells and prostaglandins in the control of metastasis.
Fulton AM
J Natl Cancer Inst; 1987 Apr; 78(4):735-41. PubMed ID: 3470548
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.
Furuta Y; Hall ER; Sanduja S; Barkley T; Milas L
Cancer Res; 1988 Jun; 48(11):3002-7. PubMed ID: 3130182
[TBL] [Abstract][Full Text] [Related]
13. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model.
Barati AH; Mokhtari-Dizaji M; Mozdarani H; Bathaie SZ; Hassan ZM
Ultrasound Med Biol; 2009 May; 35(5):756-63. PubMed ID: 19195770
[TBL] [Abstract][Full Text] [Related]
14. Effects of indomethacin on the growth of cultured mammary tumors.
Fulton AM
Int J Cancer; 1984 Mar; 33(3):375-9. PubMed ID: 6698639
[TBL] [Abstract][Full Text] [Related]
15. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of indomethacin on the growth of N-nitrosomethylurea-induced rat mammary tumors.
Pérez-López FR; Lorenzo HK; Urcia MA; Hergueta J; Lafarga L; Guillen V
Rev Esp Oncol; 1985; 32(1):15-21. PubMed ID: 3843001
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
20. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
